Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin vs Norepinephrine in Vasoplegic Syndrome After Cardiac Surgery
NCT06934798Phase 4Recruiting
- Sponsor
- Universidade de São Paulo
- Start
- Apr 2024
- Primary completion
- Jul 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of vasopressin in vasoplegic syndrome (VPS), sponsored by Universidade de São Paulo. Started Apr 2024; status: recruiting.
02
Drugs
vasopressin
03
Conditions
vasoplegic syndrome (VPS)
Beyond the preview
Go deeper on NCT06934798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06934798.